Insight Molecular Diagnostics Inc. (IMDX)

NCM – Real Time Price. Currency in USD

4.39

-0.04 (-0.78%)

Market open: Aug 12, 2026, 10:05 AM EDT

4.43

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

958K

Cost of goods sold

-4M

-3M

-6M

Gross Profit

190K

-666K

-1M

-5M

Operating expenses (excl. COGS)

-31M

-23M

-21M

-24M

Operating Income

-31M

-23M

-22M

-29M

Non-operating income, total

-20M

-37M

-3M

10M

Pretax income

-50M

-61M

-25M

-19M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-50M

-61M

-25M

-19M

Discontinued operations

-3M

-54M

Net income

-50M

-61M

-28M

-73M

Dilution adjustment

Preferred dividends

263K

942K

520K

Insight Molecular Diagnostics Inc. (IMDX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Insight Molecular Diagnostics Inc. (IMDX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Insight Molecular Diagnostics Inc. (IMDX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Insight Molecular Diagnostics Inc. (IMDX)

Income Statement (Annual)

Income Statement (Annual)